Adtalem Global Education (NYSE:CVSA) SVP Sells 4,526 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 4,526 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.81, for a total value of $614,676.06. Following the completion of the transaction, the senior vice president directly owned 28,544 shares of the company’s stock, valued at approximately $3,876,560.64. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of Adtalem Global Education stock traded down $2.73 during midday trading on Tuesday, hitting $125.98. 329,097 shares of the company were exchanged, compared to its average volume of 372,013. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market capitalization of $4.29 billion, a price-to-earnings ratio of 17.89, a P/E/G ratio of 1.05 and a beta of 0.62. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26. The firm has a 50 day simple moving average of $124.82.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Equities research analysts expect that Adtalem Global Education Inc. will post 8.95 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have recently weighed in on CVSA. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Truist Financial boosted their price target on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Finally, Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.